INOVIO PHARMACEUTICALS, INC. reports

Company location: Plymouth Meeting, PA
Fiscal year end: 31 December

INOVIO PHARMACEUTICALS, INC. has filed 1,289 SEC EDGAR filings since 29 Jun 1999

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 276-300 of 873 matching filings.

Per page

25

Current page

12

8-K File 001-14888

8-K

Filing date: 29 Oct 2021
Reporting date: 28 Oct 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-14888

8-K

Filing date: 28 Oct 2021
Reporting date: 26 Oct 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 11 Aug 2021
Reporting date: 09 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-14888

10-Q

Filing date: 09 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 11 Jun 2021
Reporting date: 09 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Jun 2021
Reporting date: 09 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Jun 2021
Reporting date: 09 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-14888

8-K

Filing date: 11 Jun 2021
Reporting date: 07 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jun 2021
Reporting date: 03 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-14888

8-K

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-14888

10-Q

Filing date: 10 May 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 21 Apr 2021
Reporting date: 21 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Apr 2021
Reporting date: 21 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Apr 2021
Reporting date: 16 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 26 Mar 2021
Reporting date: 25 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-14888

DEF 14A

Filing date: 25 Mar 2021
Reporting date: 31 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Mar 2021
Reporting date: 21 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .